Get started
Author

Aliasgar Esmail

Observed names: A Esmail, A. Esmail, Ali Esmail, Dr Aliasgar Esmail, Esmail, Aliasgar
Observed institutions: South African Medical Research Council, University of Cape Town, University of Toronto, University of the Witwatersrand, Groote Schuur Hospital, London School of Hygiene & Tropical Medicine
ORCID: 0000-0002-1835-9252
Observed ORCID: 0000-0002-1835-9252
OpenAlex ID: A5006317460
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
2021 · Shabir A. Madhi, Vicky Baillie, et al. · New England Journal of Medicine · 1,258
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
2017 · Keertan Dheda, Tawanda Gumbo, et al. · The Lancet Respiratory Medicine · 733
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
2018 · Nafees Ahmad, Shama D Ahuja, et al. · The Lancet · 664
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
2021 · Vivek Shinde, Sutika Bhikha, et al. · New England Journal of Medicine · 618
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
2022 · Keertan Dheda, Tahlia Perumal, et al. · The Lancet Respiratory Medicine · 316
PDF
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
2017 · Sergey E. Borisov, Keertan Dheda, et al. · European Respiratory Journal · 309
PDF
Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
2016 · Grant Theron, Rouxjeane Venter, et al. · Clinical Infectious Diseases · 166
False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes
2018 · Grant Theron, Rouxjeane Venter, et al. · Journal of Clinical Microbiology · 131
PDF
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
2017 · Keertan Dheda, Jason D Limberis, et al. · The Lancet Respiratory Medicine · 129
PDF
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
2018 · Olatunde Olayanju, Jason Limberis, et al. · European Respiratory Journal · 128
PDF
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
2019 · Keertan Dheda, Tawanda Gumbo, et al. · The Lancet Respiratory Medicine · 114
PDF
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)
2022 · Aliasgar Esmail, Suzette Oelofse, et al. · American Journal of Respiratory and Critical Care Medicine · 109
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data
2023 · Tobias Broger, Lisa Koeppel, et al. · The Lancet Global Health · 90
PDF
Chest X-ray Analysis With Deep Learning-Based Software as a Triage Test for Pulmonary Tuberculosis: An Individual Patient Data Meta-Analysis of Diagnostic Accuracy
2021 · Gamuchirai Tavaziva, Miriam Harris, et al. · Clinical Infectious Diseases · 86
Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis
2016 · K. Dheda, K.C. Chang, et al. · Clinical Microbiology and Infection · 76
Recent controversies about MDR and XDR‐TB : G lobal implementation of the WHO shorter MDR‐TB regimen and bedaquiline for all with MDR‐TB ?
2017 · Keertan Dheda, Helen Cox, et al. · Respirology · 75
PDF
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
2020 · Grant Theron, Jason Limberis, et al. · Nature Medicine · 69
Profiles of Volatile Biomarkers Detect Tuberculosis from Skin
2021 · Rotem Vishinkin, Rami Busool, et al. · Advanced Science · 64
PDF
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
2022 · Shabir A Madhi, Dhayendre Moodley, et al. · The Lancet HIV · 62
PDF
Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial
2015 · Gregory L Calligaro, Grant Theron, et al. · The Lancet Respiratory Medicine · 51
Socioeconomic factors impact the risk of HIV acquisition in the township population of South Africa: A Bayesian analysis
2023 · Cindy Leung Soo, Nitika Pant Pai, et al. · PLOS Global Public Health · 50
PDF
A Human Lung Challenge Model to Evaluate the Safety and Immunogenicity of PPD and Live Bacillus Calmette-Guérin
2019 · Malika Davids, Anil Pooran, et al. · American Journal of Respiratory and Critical Care Medicine · 49
A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
2019 · Olatunde Olayanju, Aliasgar Esmail, et al. · European Respiratory Journal · 49
PDF
Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
2019 · Richard Meldau, Philippa Randall, et al. · Journal of Clinical Microbiology · 45
Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill
2018 · Aliasgar Esmail, Natasha F. Sabur, et al. · Journal of Thoracic Disease · 44
PDF
Works count: 135
Citation count: 6,420
H-index: 34
I10-index: 54
Year
Topic
Type